Skip to content

Tablet Commander

by Cardiocom, LLC

510(k) K122285

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK122285 Date14 Aug 2012ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DRG
Device Class
Class II
Regulation
21 CFR Part 870.2910
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Tablet Commander is a Transmitter and Receiver, Physiological Signal, Radiofrequency (OpenFDA classification), designed as a software application for remote patient monitoring. It interfaces with external, FDA-cleared medical devices to collect physiological data via wired or wireless protocols, enabling real-time transmission of patient metrics to a remote database for clinical review.

Deployed on commercially available Android tablets, the Tablet Commander operates as a standalone interface for healthcare providers. It is supplied as a reusable software solution, requiring no sterilization, and is intended for use in clinical or home settings. The device holds FDA 510(k) clearance (K122285) under the DRG product code and is classified as Class II under regulation 870.2910. No MRI safety or single-use specifications are noted in the regulatory submission.

Other devices from Cardiocom, LLC

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Tablet Commander used for?

    The Tablet Commander is a software application designed to interface with FDA-cleared medical devices, collecting physiological data via wired or wireless protocols. It transmits patient metrics in real-time to a remote database for clinical review, supporting remote patient monitoring in both clinical and home settings. This allows healthcare providers to monitor patients remotely without needing direct physical access.

  • How is the Tablet Commander supplied and does it require sterilization?

    The Tablet Commander is supplied as a reusable software solution installed on commercially available Android tablets. Since it is software-based and does not involve physical hardware that comes into direct contact with patients, no sterilization is required. This makes it cost-effective and convenient for long-term use in various environments.

  • Is the Tablet Commander intended for single-use or reusable applications?

    The Tablet Commander is explicitly designed as a reusable software solution. It operates on Android tablets and is not limited by a single-use lifecycle, allowing healthcare providers to deploy it repeatedly across multiple patients and settings without replacement. This aligns with its classification as a reusable medical device software.

  • What types of devices does the Tablet Commander interface with?

    The Tablet Commander interfaces with external, FDA-cleared medical devices that transmit physiological data via wired or wireless protocols. While the specific devices are not listed in the data, its regulatory classification under OpenFDA as a 'Transmitter and Receiver, Physiological Signal, Radiofrequency' suggests compatibility with a broad range of cardiovascular and monitoring devices approved for remote data transmission.

  • What regulatory approval does the Tablet Commander hold?

    The Tablet Commander holds FDA 510(k) clearance under the product code DRG, with the clearance number K122285. It is classified as a Class II device under regulation 870.2910, indicating it has been determined to be substantially equivalent to a legally marketed predicate device. This approval supports its use for remote patient monitoring in clinical settings.